Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Palatin Technologies Inc
0KF3Current price
1.47 USD
-0.15 USD (-9.21%)
Last closed
1.46 USD
Company
palatin.com
ISIN
US6960774031
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
28 667 452 USD
Yield for 12 month
-24.87 %
1Y
3Y
5Y
10Y
15Y
0KF3
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that is in Phase 2 clinical trial for the treatment of inflammatory bowel diseases. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease, which is in Phase 3 clinical trial; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL8177, an oral peptide formulation for treatment of ulcerative colitis, which entered Phase 2 clinical trials. The company was founded in 1986 and is based in Cranbury, New Jersey. Address: Cedar Brook Corporate Center, Cranbury, NJ, United States, 08512
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.67 USDP/E ratio
–Dividend Yield
–Current Year
+4 853 678 USD
Last Year
+1 468 457 USD
Current Quarter
–
Last Quarter
+2 034 113 USD
Current Year
+4 435 208 USD
Last Year
+1 250 928 USD
Current Quarter
-171 789 USD
Last Quarter
+1 766 238 USD
Key Figures 0KF3
1 year
3 years
5 years
10 years
EBITDA
-32 432 260 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-110.67 %
PEG Ratio
–
Return On Equity TTM
-623.2 %
Wall Street Target Price
8.67 USD
Revenue TTM
5 902 023 USD
Book Value
0.098 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
98.2 %
Dividend Yield
–
Gross Profit TTM
-18 195 369 USD
Earnings per share
-2.72 USD
Diluted Eps TTM
-2.72 USD
Most Recent Quarter
I 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0KF3
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0KF3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
31.08.2022
Dividend Date
–
Stock Valuation 0KF3
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.2802
Price Sales TTM
4.8572
Enterprise Value EBITDA
-0.6433
Price Book MRQ
18.1567
Financials 0KF3
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0KF3
For 52 weeks
1.29 USD
5.65 USD
50 Day MA
1.62 USD
Shares Short Prior Month
1 182 689
200 Day MA
2.25 USD
Short Ratio
11.16
Shares Short
1 417 818
Short Percent
7.43 %
BeatStart